Invivyd Inc
Invivyd Inc logo

Invivyd Inc (IVVD)


Market is closed
– opens on 7 PM, 07 Oct 2022
  • $

Company Information

Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with third-party contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.
OrganizationInvivyd Inc
CEOMr. David Hering M.B.A.


Market Capitalization
Book Value
Dividend Share
Dividend Yield
Wall Street Target Price


Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
Enterprise Value
Enterprise Value/Revenue
Enterprise Value/Ebitda


50 Day MA
200 Day MA

Discover more

Frequently Asked Questions

What is Invivyd Inc share price today?

Can Indians buy Invivyd Inc shares?

How can I buy Invivyd Inc shares from India?

Can Fractional shares of Invivyd Inc be purchased?

What are the documents required to start investing in Invivyd Inc stocks?

What are today’s High and Low prices of Invivyd Inc?

What are today’s traded volumes of Invivyd Inc?

What is today’s market capitalisation of Invivyd Inc?

What is the 52 Week High and Low Range of Invivyd Inc?

How much percentage Invivyd Inc is down from its 52 Week High?

How much percentage Invivyd Inc is up from its 52 Week low?

What are the historical returns of Invivyd Inc?

Who is the Chief Executive Officer (CEO) of Invivyd Inc?